Price
140.27
+1.6%52W Range
Market Cap
₹1,615.40 Cr
Traded: ₹2.16 Cr (0.13%) 0.0x
Free Float: ₹397.87 Cr (0.54% of FF traded)
Volume · 60D trend
1.53 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | -- | +10.0% | +6.0% | -- | +17.0% | Stable |
| ROE | -- | +15.0% | +10.0% | -- | -- | Decelerating |
| Return | -- | -14.0% | -10.0% | -30.0% | -- | Stable |
| Profit | -- | -2.0% | -6.0% | -- | +9.0% | Stable |
Quarterly Results
Dec 2022
Sep 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023PDF ↗ | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 252 | 266 | 225 | 290 | 275 | 207 | 172 | 229 | 220 | 126 | 151 | 202 | 201 | 198 | 218 | 251 |
| Expenses | 216 | 225 | 188 | 242 | 230 | 176 | 146 | 195 | 192 | 122 | 118 | 175 | 179 | 156 | 171 | 198 |
| Operating Profit | 35 | 42 | 38 | 49 | 45 | 32 | 27 | 34 | 28 | 4 | 33 | 27 | 23 | 42 | 47 | 53 |
| OPM % | 14.0% | 16.0% | 17.0% | 17.0% | 16.0% | 15.0% | 15.0% | 15.0% | 13.0% | 3.0% | 22.0% | 13.0% | 11.0% | 21.0% | 21.0% | 21.0% |
| Other Income | 4 | 4 | 3 | 5 | 9 | 3 | 3 | 5 | 4 | 4 | 4 | 4 | 3 | 3 | 5 | 2 |
| Interest | 3 | 3 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| Depreciation | 6 | 5 | 6 | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 |
| Profit Before Tax | 31 | 38 | 34 | 47 | 47 | 29 | 23 | 34 | 27 | 2 | 32 | 27 | 21 | 40 | 46 | 50 |
| Tax % | 26.0% | 19.0% | 33.0% | 33.0% | 26.0% | 25.0% | 31.0% | 23.0% | 27.0% | 47.0% | 26.0% | 26.0% | 27.0% | 26.0% | 25.0% | 26.0% |
| Net Profit | 23 | 31 | 23 | 32 | 35 | 22 | 16 | 26 | 19 | 1 | 24 | 20 | 16 | 30 | 35 | 37 |
| Exceptional Items | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS (Rs) | 2.0 | 2.7 | 2.0 | 2.7 | 3.0 | 1.9 | 1.4 | 2.3 | 1.7 | 0.1 | 2.1 | 1.7 | 1.4 | 2.6 | 3.0 | 3.2 |
| Sales Growth (YoY) | -8.4% | 28.5% | 30.8% | 26.6% | 25.0% | 64.3% | 13.9% | 13.4% | 9.4% | -36.4% | -30.7% | -19.5% | -- | -- | -- | -- |
| Sales Growth (QoQ) | -5.3% | 18.2% | -22.4% | 5.5% | 32.9% | 20.4% | -24.9% | 4.1% | 74.6% | -16.6% | -25.3% | 0.5% | 1.5% | -9.2% | -13.2% | -- |
| OP Growth (YoY) | -22.2% | 31.3% | 40.7% | 44.1% | 60.7% | 700.0% | -18.2% | 25.9% | 21.7% | -90.5% | -29.8% | -49.1% | -- | -- | -- | -- |
| OP Growth (QoQ) | -16.7% | 10.5% | -22.4% | 8.9% | 40.6% | 18.5% | -20.6% | 21.4% | 600.0% | -87.9% | 22.2% | 17.4% | -45.2% | -10.6% | -11.3% | -- |
| Profit Growth (YoY) | -- | 40.6% | 41.2% | 22.0% | 79.2% | 1953.8% | -33.0% | 32.9% | 25.5% | -96.5% | -31.1% | -47.6% | -62.2% | -2.2% | -19.4% | -11.6% |
| EPS Growth (YoY) | -35.0% | 40.7% | 40.7% | 21.8% | 79.3% | 2000.0% | -32.7% | 33.1% | 25.2% | -96.5% | -31.1% | -47.7% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -25.9% | 35.0% | -28.1% | -9.6% | 60.3% | 35.0% | -37.8% | 33.1% | 1777.8% | -95.7% | 23.1% | 25.2% | -48.1% | -13.9% | -6.5% | -- |
| OP Margin | 13.9% | 15.8% | 16.9% | 16.9% | 16.4% | 15.5% | 15.7% | 14.8% | 12.7% | 3.2% | 21.9% | 13.4% | 11.4% | 21.2% | 21.6% | 21.1% |
| Net Margin | 9.1% | 11.7% | 10.2% | 11.0% | 12.7% | 10.6% | 9.3% | 11.3% | 8.6% | 0.8% | 15.9% | 9.9% | 8.0% | 15.2% | 16.1% | 14.7% |
| Material Cost % | -- | 54.0% | 51.0% | 56.0% | 57.0% | 53.0% | 48.0% | 57.0% | 62.0% | 53.0% | 47.0% | 64.0% | 65.0% | 55.0% | 55.0% | 57.0% |
| Employee Cost % | -- | 6.0% | 8.0% | 5.0% | 5.0% | 7.0% | 8.0% | 6.0% | 6.0% | 9.0% | 7.0% | 5.0% | 5.0% | 4.0% | 4.0% | 4.0% |
| P/S | 1.56 | 1.68 | 1.81 | 1.92 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 15.02 | 14.82 | 16.26 | 17.37 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 1.60 | 1.76 | 1.88 | 1.89 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Earning Call Transcript for Q1 FY27
Audio recording of earnings conference call for the quarter ended 30th June, 2026
Newspaper Publication after dispatching AGM Notice.
Annual Report of the Company for the F.Y. 2025-26
Business Responsibility & Sustainability Report for the year ended 31st March, 2026.
Notice of the 41st AGM of the Company
Financial Results for the quarter ended 30th June, 2026
India Pesticides Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2026 ,inter alia, to consider and approve Un-audited Standalone and ....
Intimation regarding approval of the fungicide
Intimation regarding approval of the Fungicide.
certificate under regulation 74(5) of SEBI (DP) Regulations, 2018
Income Tax Demand Notice under section 156 of Income Tax Act, 1961
Closure of Trading Window for the quarter ended 30th June, 2026
Intimation regarding conferment of Lifetime Achievement Award
Intimation regarding reconstitution of the Committees
Intimation for Resignation of Director
Intimation regarding approval of the Fungicide
Earning call transcript for the quarter and year ended 31st march, 2026
Audio recording of earnings conference call for the quarter & year ended 31st March 2026
Press release for the quarter and year ended 31st March, 2026
Investor Presentation for the quarter and year ended 31st March, 2026
Annual Secretarial Compliance Report for the year ended 31st March, 2026
Newspaper Publication
Shareholders meeting dated 31st August, 2026
Declaration of Dividend
outcome of the Board Meeting
Declaration of Dividend
Financial Results for the quarter and year ended 31st March, 2026
Schedule of Analyst/Investor Meet.
India Pesticides Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2026 ,inter alia, to consider and approve To consider and approve the ....
Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Satya Prakash Gupta
Closure Of Trading Window
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Satya Prakash Gupta
Intimation of Plant visit and Management Interaction
Scrutinizer report of Postal Ballot
outcome of the Postal Ballot
Earnings call transcript
Audio recording of earning conference call
Investor Presentation for the quarter ended 31st December, 2025.
Newspaper Publication of Unaudited Financial Results
Press Release for the unaudited Financial Results
Financial Results for the quarter ended 31st December, 2025
Re-appointment of Mr. Dheeraj Kumar Jain as CEO & KMP of the Company
Outcome of the Board Meeting
Revision in Schedule of Earnings Conference Call - Q3 FY26
Intimation of Newspaper publication for postal ballot notice
Notice of Postal Ballot
Intimation of Q3 FY26 Earning Conference Call with Analysts/Investors to discuss Un-audited Standalone and Consolidated Financial Results of the Company for the quarter ended 31st December 2025
India Pesticides Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 ,inter alia, to consider and approve the Un-audited Standalone ....
Credit Ratings
6Concalls
23Feb 2026
28 Feb 2026Nov 2025
30 Nov 2025Aug 2025
31 Aug 2025Jun 2025
30 Jun 2025Feb 2025
28 Feb 2025Nov 2024
30 Nov 2024Aug 2024
31 Aug 2024Aug 2024
31 Aug 2024Jun 2024
30 Jun 2024Feb 2024
29 Feb 2024Nov 2023
30 Nov 2023Aug 2023
31 Aug 2023Jun 2023
30 Jun 2023Jun 2023
30 Jun 2023Feb 2023
28 Feb 2023Nov 2022
30 Nov 2022Aug 2022
31 Aug 2022Jun 2022
30 Jun 2022May 2022
31 May 2022Feb 2022
28 Feb 2022Feb 2022
28 Feb 2022Oct 2021
31 Oct 2021Jul 2021
31 Jul 2021Held by Mutual Funds
1 schemes hold ipl · sorted by weight